Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 13;20(1):266.
doi: 10.1186/s12936-021-03793-0.

Evaluation of the effect of supervised anti-malarial treatment on recurrences of Plasmodium vivax malaria

Affiliations

Evaluation of the effect of supervised anti-malarial treatment on recurrences of Plasmodium vivax malaria

Kelry Mazurega Oliveira Dinelly et al. Malar J. .

Abstract

Background: Relapses in vivax malaria have posed great challenges for malaria control, and they also account for a great proportion of reported cases. Knowing the real effectiveness of a 7-day primaquine (PQ) scheme is crucial in order to evaluate not only the cost-effectiveness of implementing new anti-hypnozoite drugs, but also how health education strategies can guarantee better compliance and be reinforced. This study aimed to evaluate the effect of daily treatment with chloroquine and PQ supervised by health workers versus prescription without supervision.

Methods: The outcome was the passive detection of new positive thick blood smears up to 180 days, based on the official data records from the National Malaria Control Programme. The recurrences seen in the real life were, therefore, used as a surrogate for true relapses.

Results: Patients under supervised treatment had a lower risk of recurrence up to day 180 when compared to the unsupervised treatment (17.9% vs. 36.1%; p = 0.027).

Conclusions: The lack of supervision in the non-supervised group (which followed standard of care in the real life) enabled proper comparison, as consent itself would have lead to greater compliance in this group. Future studies should scale such an analysis to different settings in the Brazilian Amazon.

Keywords: Malaria; Plasmodium vivax; Recurrence; Supervised treatment; Unsupervised treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Time to first recurrence in the groups of supervised and unsupervised 7-day primaquine treatment in 180 days of follow-up. PQ, primaquine; HR, hazard ratio; CI, confidence interval

References

    1. Ministério da Saúde. Secretaria de Vigilância em Saúde. Guia prático de Tratamento da Malária no Brasil. Departamento de Vigilância Epidemiológica, Brasília; 2020. https://bvsms.saude.gov.br/bvs/publicacoes/guia_pratico_malaria.pdf. Accessed 10 Jan 2021.
    1. Ministério da Saúde. Secretaria de Vigilância em Saúde. Guia para gestão Local do Controle da Malária: Controle Vetorial. Brasília; 2008. http://bvsms.saude.gov.br/bvs/publicacoes/guia_gestao_local_controle_vet.... Accessed 12 Jan 2021.
    1. Commons RJ, Simpson JA, Thriemer K, Humphreys GS, Abreha T, Alemu SG, et al. The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis. Lancet Infect Dis. 2018;18:1025–34. doi: 10.1016/S1473-3099(18)30348-7. - DOI - PMC - PubMed
    1. Vieira GD, Gim KNM, Zaqueo GM, Alves TC, Katsuragawa TH, Basano SA, et al. Reduction of incidence and relapse or recrudescence cases of malaria in the western region of the Brazilian Amazon. J Infect Dev Ctries. 2014;8:1181–7. doi: 10.3855/jidc.4422. - DOI - PubMed
    1. Vitor-Silva S, Siqueira AM, de Souza Sampaio V, Guinovart C, Reyes-Lecca RC, de Melo GC, et al. Declining malaria transmission in rural Amazon: changing epidemiology and challenges to achieve elimination. Malar J. 2016;15:266. doi: 10.1186/s12936-016-1326-2. - DOI - PMC - PubMed

Grants and funding

LinkOut - more resources